The riboflavin biosynthetic pathway as a novel target for antifungal drugs against Candida species
Jana Nysten, Arne Peetermans, Dries Vaneynde, Stef Jacobs, Liesbeth Demuyser, Patrick Van Dijck
This paper identifies the riboflavin biosynthetic pathway as a novel antifungal target in Candida species, showing that key enzymes are essential and that riboflavin uptake mechanisms differ among species.
mBio · Oct 15, 2024Peer-reviewedMicrobiology